301130 西点药业
交易中 02-24 10:12:30
资讯
新帖
简况
西点药业（301130）披露回购股份事项前十名股东持股情况公告，2月3日股价上涨2.33%
证券之星 · 02-03
西点药业（301130）披露回购股份事项前十名股东持股情况公告，2月3日股价上涨2.33%
西点药业（301130）披露使用闲置募集资金进行现金管理的公告，1月28日股价下跌1.9%
证券之星 · 01-28
西点药业（301130）披露使用闲置募集资金进行现金管理的公告，1月28日股价下跌1.9%
西点药业(301130.SZ)拟斥2500万元至5000万元实施回购
智通财经 · 01-22
西点药业(301130.SZ)拟斥2500万元至5000万元实施回购
西点药业最新公告：硫酸氨基葡萄糖胶囊获得药品注册证书
证券之星 · 01-22
西点药业最新公告：硫酸氨基葡萄糖胶囊获得药品注册证书
西点药业最新公告：拟设立全资子公司西点大药房
证券之星 · 01-22
西点药业最新公告：拟设立全资子公司西点大药房
股市必读：西点药业（301130）1月9日董秘有最新回复
证券之星 · 01-12
股市必读：西点药业（301130）1月9日董秘有最新回复
西点药业：暂未布局脑机接口行业
证券之星 · 01-09
西点药业：暂未布局脑机接口行业
西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，12月03日股价上涨2.17%
证券之星 · 2025-12-03
西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，12月03日股价上涨2.17%
西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，11月25日股价上涨2.15%
证券之星 · 2025-11-25
西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，11月25日股价上涨2.15%
11月19日西点药业发布公告，股东减持45.38万股
证券之星 · 2025-11-19
11月19日西点药业发布公告，股东减持45.38万股
西点药业：重酒石酸利斯的明口服溶液2025年上市销售
中金财经 · 2025-11-19
西点药业：重酒石酸利斯的明口服溶液2025年上市销售
股市必读：西点药业（301130）11月14日董秘有最新回复
证券之星 · 2025-11-17
股市必读：西点药业（301130）11月14日董秘有最新回复
西点药业：优化营销策略提升核心产品业绩
证券之星 · 2025-11-14
西点药业：优化营销策略提升核心产品业绩
股市必读：10月31日西点药业现1笔折价21.38%的大宗交易 合计成交219.15万元
证券之星 · 2025-11-03
股市必读：10月31日西点药业现1笔折价21.38%的大宗交易 合计成交219.15万元
西点药业：国内唯一瑞香素原料药生产企业
证券之星 · 2025-10-29
西点药业：国内唯一瑞香素原料药生产企业
10月27日西点药业现1笔折价21.4%的大宗交易 合计成交461.65万元
证券之星 · 2025-10-27
10月27日西点药业现1笔折价21.4%的大宗交易 合计成交461.65万元
西点药业(301130.SZ)发布前三季度业绩，归母净利润3314.64万元，下降2.7%
智通财经 · 2025-10-27
西点药业(301130.SZ)发布前三季度业绩，归母净利润3314.64万元，下降2.7%
10月24日西点药业现1笔折价20.03%的大宗交易 合计成交1304.99万元
证券之星 · 2025-10-24
10月24日西点药业现1笔折价20.03%的大宗交易 合计成交1304.99万元
股市必读：西点药业（301130）10月23日董秘有最新回复
证券之星 · 2025-10-24
股市必读：西点药业（301130）10月23日董秘有最新回复
西点药业：拥有抗流感药物复方氨酚烷胺胶囊
证券之星 · 2025-10-23
西点药业：拥有抗流感药物复方氨酚烷胺胶囊
暂无数据
公司概况
公司名称：
吉林省西点药业科技发展股份有限公司
所属行业：
医药制造业
上市日期：
2022-02-23
主营业务：
吉林省西点药业科技发展股份有限公司的主营业务是化学药品原料药及制剂的研发、生产、销售。公司的主要产品是抗贫血用药、抗精神病用药、抗抑郁用药、循环系统用药、富马酸亚铁、硫酸亚铁、瑞香素。
发行价格：
22.55
{"stockData":{"symbol":"301130","market":"SZ","secType":"STK","nameCN":"西点药业","latestPrice":31.87,"timestamp":1771899150000,"preClose":31.52,"halted":0,"volume":422900,"delay":0,"changeRate":0.0111,"floatShares":59017400,"shares":76494700,"eps":0.5144,"marketStatus":"交易中","change":0.35,"latestTime":"02-24 10:12:30","open":32.05,"high":32.05,"low":31.49,"amount":13446700,"amplitude":0.0178,"askPrice":31.88,"askSize":11,"bidPrice":31.87,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.5144,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1771903800000},"marketStatusCode":2,"adr":0,"adjPreClose":31.52,"symbolType":"stock","openAndCloseTimeList":[[1771896600000,1771903800000],[1771909200000,1771916400000]],"highLimit":34.67,"lowLimit":28.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":76494685,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":61.955677,"roe":"3.63%","epsLYR":0.5173,"committee":-0.139665,"marketValue":2438000000,"turnoverRate":0.0072,"status":0,"floatMarketCap":1881000000},"requestUrl":"/m/hq/s/301130/tweets","defaultTab":"tweets","newsList":[{"id":"2608870336","title":"西点药业（301130）披露回购股份事项前十名股东持股情况公告，2月3日股价上涨2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608870336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608870336?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:45","pubTimestamp":1770129921,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，西点药业报收于31.66元，较前一交易日上涨2.33%，最新总市值为24.22亿元。该股当日开盘31.48元，最高31.66元，最低31.12元，成交额达3991.62万元，换手率为2.15%。公司于近日发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2606710949","title":"西点药业（301130）披露使用闲置募集资金进行现金管理的公告，1月28日股价下跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606710949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606710949?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:51","pubTimestamp":1769611873,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，西点药业报收于31.02元，较前一交易日下跌1.9%，最新总市值为23.73亿元。该股当日开盘31.5元，最高31.62元，最低30.9元，成交额达3106.6万元，换手率为1.69%。近日，吉林省西点药业科技发展股份有限公司披露《关于使用闲置募集资金进行现金管理的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800043262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2605462138","title":"西点药业(301130.SZ)拟斥2500万元至5000万元实施回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2605462138","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605462138?lang=zh_cn&edition=full","pubTime":"2026-01-22 18:14","pubTimestamp":1769076887,"startTime":"0","endTime":"0","summary":"智通财经APP讯，西点药业(301130.SZ)公告，公司拟回购公司股份用于实施员工持股计划或股权激励。回购股份的资金总额不低于2500万元(含)，不超过5000万元(含)。回购股份的价格不超过42.00元/股(含)。回购股份的实施期限自公司董事会审议通过本次回购股份方案之日起12个月内","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2605464161","title":"西点药业最新公告：硫酸氨基葡萄糖胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2605464161","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605464161?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:44","pubTimestamp":1769075091,"startTime":"0","endTime":"0","summary":"西点药业(301130.SZ)公告称，公司于近日收到国家药品监督管理局签发的硫酸氨基葡萄糖胶囊《药品注册证书》。该产品用于原发性或继发性骨关节炎，注册分类为化学药品4类，批准文号为国药准字H20255903。该产品的获批丰富了公司产品线，提升市场竞争力，但销售受行业政策、招标采购等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2605146413","title":"西点药业最新公告：拟设立全资子公司西点大药房","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146413","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605146413?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:44","pubTimestamp":1769075047,"startTime":"0","endTime":"0","summary":"西点药业(301130.SZ)公告称，公司拟使用自有资金200万元人民币在吉林省磐石市投资设立全资子公司西点大药房有限公司，并授权公司管理层办理相关设立登记事宜。该事项无需提交股东大会审议，不涉及关联交易，亦不属于重大资产重组。设立全资子公司旨在开拓市场，促进公司业务发展，不会对公司财务及经营状况产生重大不利影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2602209552","title":"股市必读：西点药业（301130）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602209552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602209552?lang=zh_cn&edition=full","pubTime":"2026-01-12 01:48","pubTimestamp":1768153692,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，西点药业报收于30.46元，上涨3.11%，换手率4.18%，成交量2.44万手，成交额7418.23万元。董秘最新回复投资者： 董秘 您好 公司产品可以用于脑机接口吗？公司一直致力于化学原料药及制剂的研发、生产和销售，并不断加深公司的创新性属性。公司暂未布局脑机接口行业，感谢您的关注！交易信息汇总资金流向1月9日主力资金净流入1254.77万元；游资资金净流出337.3万元；散户资金净流出917.47万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2602666340","title":"西点药业：暂未布局脑机接口行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2602666340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602666340?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:15","pubTimestamp":1767942919,"startTime":"0","endTime":"0","summary":"证券之星消息，西点药业(301130)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘 您好 公司产品可以用于脑机接口吗？公司有考虑布局脑机接口领域吗？谢谢西点药业回复：尊敬的投资者，您好！公司一直致力于化学原料药及制剂的研发、生产和销售，并不断加深公司的创新性属性。公司暂未布局脑机接口行业，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2588004290","title":"西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，12月03日股价上涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588004290","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588004290?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:33","pubTimestamp":1764772399,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，西点药业报收于30.64元，较前一交易日上涨2.17%，最新总市值为23.44亿元。公司近日发布公告称，于2025年1月20日召开董事会及监事会，审议通过使用不超过1.0亿元闲置募集资金进行现金管理。近期，公司赎回兴业银行结构性存款本金4,500万元，获得收益4.81万元。随后继续使用闲置募集资金合计5,500万元购买兴业银行和平安银行的结构性存款产品，产品起息日为2025年12月2日，到期日为2026年1月15日，资金来源均为募集资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2586672471","title":"西点药业（301130）披露使用闲置募集资金进行现金管理到期赎回并继续进行现金管理，11月25日股价上涨2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586672471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586672471?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:39","pubTimestamp":1764081580,"startTime":"0","endTime":"0","summary":"截至2025年11月25日收盘，西点药业报收于30.93元，较前一交易日上涨2.15%，最新总市值为23.66亿元。该股当日开盘30.47元，最高31.26元，最低30.3元，成交额达4503.46万元，换手率为2.49%。公司近日发布公告称，使用闲置募集资金进行现金管理，近期赎回平安银行结构性存款1,200万元，获得收益4.79万元。上述操作在董事会授权额度和期限内，无需另行审议。公司累计使用闲置募集资金进行现金管理未到期余额为7,500万元，未超出授权额度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500039910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2584948854","title":"11月19日西点药业发布公告，股东减持45.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584948854","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584948854?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:01","pubTimestamp":1763550091,"startTime":"0","endTime":"0","summary":"证券之星消息，11月19日西点药业发布公告《西点药业:关于持股5%以上股东及其一致行动人股份减持计划时间届满暨减持结果的公告》，其股东珠海横琴润汇易投资合伙企业(有限合伙)于2025年11月4日至2025年11月18日间合计减持45.38万股，占公司目前总股本的0.5932%，变动期间该股股价上涨4.0%，截止11月18日收盘报32.22元。股东增减持详情见下表：根据西点药业2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900032825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2584788915","title":"西点药业：重酒石酸利斯的明口服溶液2025年上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2584788915","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584788915?lang=zh_cn&edition=full","pubTime":"2025-11-19 15:58","pubTimestamp":1763539118,"startTime":"0","endTime":"0","summary":"证券之星消息，西点药业11月19日在投资者关系平台上答复投资者关心的问题。随着老龄化时代来临，公司阿尔茨海默症相关药品是否已有销售？公司针对老年性疾病的用于治疗轻、中度阿尔茨海默型痴呆的重酒石酸利斯的明口服溶液已于2025年上市销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251119/31808707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2584695178","title":"股市必读：西点药业（301130）11月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584695178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584695178?lang=zh_cn&edition=full","pubTime":"2025-11-17 04:33","pubTimestamp":1763325189,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，西点药业报收于32.44元，上涨3.08%，换手率5.13%，成交量2.99万手，成交额9699.07万元。董秘最新回复投资者： 董秘您好！同时强烈建议公司今年高送转，提升二级市场流动性！当日关注点来自交易信息汇总：11月14日主力资金净流入60.31万元，显示主力对个股短期态度偏积极。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2583829506","title":"西点药业：优化营销策略提升核心产品业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2583829506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583829506?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:51","pubTimestamp":1763124675,"startTime":"0","endTime":"0","summary":"证券之星消息，西点药业11月13日在投资者关系平台上答复投资者关心的问题。关于公司核心产品与业绩方面，我公司一直努力深耕主业，加速公司价值的转化。您提到的关于核心产品的业绩，我们通过优化营销策略，努力提升已上市产品的销售收入，将核心产品的差异化优势转化为实实在在的市场份额和业绩贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400038472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2580231740","title":"股市必读：10月31日西点药业现1笔折价21.38%的大宗交易 合计成交219.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580231740","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580231740?lang=zh_cn&edition=full","pubTime":"2025-11-03 06:22","pubTimestamp":1762122132,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，西点药业报收于30.97元，上涨1.77%，换手率2.63%，成交量1.53万手，成交额4742.44万元。交易信息汇总资金流向10月31日主力资金净流出531.95万元；游资资金净流出386.23万元；散户资金净流入918.18万元。大宗交易10月31日西点药业发生1笔折价21.38%的大宗交易，合计成交219.15万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2579170809","title":"西点药业：国内唯一瑞香素原料药生产企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2579170809","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579170809?lang=zh_cn&edition=full","pubTime":"2025-10-29 09:01","pubTimestamp":1761699675,"startTime":"0","endTime":"0","summary":"我公司是国内唯一一家瑞香素原料药生产企业及瑞香素胶囊上市销售的药品生产企业，目前国内只有西点药业拥有瑞香素原料药药品批准文号，拥有瑞香素胶囊药品批准文的药品生产企业有包括西点药业在内的三家，因我公司瑞香素原料药是自产自用不对外销售而其余两家瑞香素胶囊批准文号拥有企业是无法生产瑞香素胶囊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900013647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2578538615","title":"10月27日西点药业现1笔折价21.4%的大宗交易 合计成交461.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578538615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578538615?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:53","pubTimestamp":1761555217,"startTime":"0","endTime":"0","summary":"证券之星消息，10月27日西点药业发生大宗交易，交易数据如下：大宗交易成交价格25.05元，相对当日收盘价折价21.4%，成交18.43万股，成交金额461.65万元，买方营业部为国泰海通证券股份有限公司北京朝阳门证券营业部，卖方营业部为国泰海通证券股份有限公司吉林南京街证券营业部。近三个月该股共发生2笔大宗交易，合计成交7055.0手，折价成交2笔。截至2025年10月27日收盘，西点药业报收于31.87元，上涨1.79%，换手率3.04%，成交量1.78万手，成交额5647.34万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2578704618","title":"西点药业(301130.SZ)发布前三季度业绩，归母净利润3314.64万元，下降2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578704618","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578704618?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:20","pubTimestamp":1761553202,"startTime":"0","endTime":"0","summary":"智通财经APP讯，西点药业(301130.SZ)发布2025年三季度报告，该公司前三季度营业收入为1.89亿元，同比减少1.89%。归属于上市公司股东的净利润为3314.64万元，同比减少2.70%。归属于上市公司股东的扣除非经常性损益的净利润为2980.86万元，同比增长3.19%。基本每股收益为0.4333元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130"],"gpt_icon":0},{"id":"2577596196","title":"10月24日西点药业现1笔折价20.03%的大宗交易 合计成交1304.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577596196","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577596196?lang=zh_cn&edition=full","pubTime":"2025-10-24 17:01","pubTimestamp":1761296496,"startTime":"0","endTime":"0","summary":"证券之星消息，10月24日西点药业发生大宗交易，交易数据如下：大宗交易成交价格25.04元，相对当日收盘价折价20.03%，成交52.12万股，成交金额1304.99万元，买方营业部为国泰海通证券股份有限公司北京朝阳门证券营业部，卖方营业部为国泰海通证券股份有限公司吉林南京街证券营业部。近三个月该股共发生1笔大宗交易，合计成交5212.0手，折价成交1笔。截至2025年10月24日收盘，西点药业报收于31.31元，上涨0.03%，换手率1.92%，成交量1.12万手，成交额3512.69万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400029454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2577532315","title":"股市必读：西点药业（301130）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577532315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577532315?lang=zh_cn&edition=full","pubTime":"2025-10-24 05:30","pubTimestamp":1761255033,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，西点药业报收于31.3元，下跌0.19%，换手率1.73%，成交量1.01万手，成交额3151.58万元。我公司现有已上市产品方面，公司拥有成熟的抗流感药物复方氨酚烷胺胶囊，以及于2025年获得批准上市的抗病毒片临床上用于治疗上呼吸道感染及流行性感冒。我公司是国内独家生产销售瑞香素胶囊的生产企业。当日关注点来自交易信息汇总：10月23日主力资金净流出86.94万元，散户资金净流入372.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2577413363","title":"西点药业：拥有抗流感药物复方氨酚烷胺胶囊","url":"https://stock-news.laohu8.com/highlight/detail?id=2577413363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577413363?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:55","pubTimestamp":1761180914,"startTime":"0","endTime":"0","summary":"证券之星消息，西点药业10月23日在投资者关系平台上答复投资者关心的问题。我公司现有已上市产品方面，公司拥有成熟的抗流感药物复方氨酚烷胺胶囊，以及于2025年获得批准上市的抗病毒片临床上用于治疗上呼吸道感染及流行性感冒。我公司是国内独家生产销售瑞香素胶囊的生产企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300006408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771899154129,"stockEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0284},{"period":"6month","weight":-0.0848},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.1044}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林省西点药业科技发展股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7863人(较上一季度减少2.91%)","perCapita":"7505股","listingDate":"2022-02-23","address":"吉林省吉林市磐石市磐石经济开发区西点大街777号","registeredCapital":"7649万元","survey":" 吉林省西点药业科技发展股份有限公司的主营业务是化学药品原料药及制剂的研发、生产、销售。公司的主要产品是抗贫血用药、抗精神病用药、抗抑郁用药、循环系统用药、富马酸亚铁、硫酸亚铁、瑞香素。","listedPrice":22.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西点药业,301130,西点药业股票,西点药业股票老虎,西点药业股票老虎国际,西点药业行情,西点药业股票行情,西点药业股价,西点药业股市,西点药业股票价格,西点药业股票交易,西点药业股票购买,西点药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}